Securities Code: 002898
Securities Abbreviation: *ST Sailong
Announcement Number: 2026-047
Sailong Pharmaceutical Group Co., Ltd. announces that the company and all members of the board guarantee that the content of the information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
On April 29, 2026, the fourth board of directors held its twenty-fifth meeting, where it reviewed and approved the proposal regarding uncovered losses exceeding one-third of the paid-in capital. This matter needs to be submitted to the shareholders' meeting for review. The specific situation is explained as follows: